+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Consumer Health in Egypt

  • ID: 2315953
  • Report
  • November 2020
  • Region: Egypt
  • 101 pages
  • Euromonitor International
Overall, consumer health is expected to perform well, due to increased demand as a result of COVID-19, with most areas product areas expected to register double-digit current value growth. Though 2020 current value growth is not expected to be as high as in 2019, a lot of the growth over the review period was driven by inflation rather than volume increases.

The publisher's Consumer Health in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
EXECUTIVE SUMMARY
  • COVID-19 impact on consumer health
  • COVID-19 country impact
  • Company response
  • Retailing shift
  • What next for consumer health?
MARKET INDICATORS
  • Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
  • Table 2 Life Expectancy at Birth 2015-2020
MARKET DATA
  • Table 3 Sales of Consumer Health by Category: Value 2015-2020
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2015-2020
  • Table 5 NBO Company Shares of Consumer Health: % Value 2016-2020
  • Table 6 LBN Brand Shares of Consumer Health: % Value 2017-2020
  • Table 7 Distribution of Consumer Health by Format: % Value 2015-2020
  • Table 8 Distribution of Consumer Health by Format and Category: % Value 2020
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2020-2025
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES
  • Summary 1 Research Sources
KEY DATA FINDINGS

2020 IMPACT
  • Stockpiling leads to healthy value growth
  • GSK’s range of strong brands ensures the company’s ongoing leadership
  • Aspirin and ibuprofen register slower demand as all categories record strong growth
RECOVERY AND OPPORTUNITIES
  • Analgesics sales normalise to pre COVID-19 levels by 2022
  • Strong growth due to population growth and consistent demand throughout the year
  • Rising demand for diclofenac
CATEGORY DATA
  • Table 11 Sales of Analgesics by Category: Value 2015-2020
  • Table 12 Sales of Analgesics by Category: % Value Growth 2015-2020
  • Table 13 NBO Company Shares of Analgesics: % Value 2016-2020
  • Table 14 LBN Brand Shares of Analgesics: % Value 2017-2020
  • Table 15 Forecast Sales of Analgesics by Category: Value 2020-2025
  • Table 16 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Cough remedies benefit from COVID-19
  • GSK inherits strong brands to become leading player
  • Demand remains highly seasonal in all product areas
RECOVERY AND OPPORTUNITIES
  • Growth in value sales decline in 2021 due to stockpiling
  • Value sales continue to be supported by strong preference for self-medication
  • Rigid price controls stymies growth during the forecast period
CATEGORY DATA
  • Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
  • Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
  • Table 19 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
  • Table 20 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
  • Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
  • Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Stockpiling as a result of COVID-19 leads to volume increase
  • Altana is new leader as its heartburn brand Controloc registers significant value sales
  • Sales continue to be dominated by indigestion and heartburn remedies
RECOVERY AND OPPORTUNITIES
  • Further lockdown could lead to less food poisoning and less demand for digestive remedies
  • Food poisoning a common source of sales for digestive remedies
  • High demand among low-income consumers supports sales of cheaper brands and generics
CATEGORY DATA
  • Table 23 Sales of Digestive Remedies by Category: Value 2015-2020
  • Table 24 Sales of Digestive Remedies by Category: % Value Growth 2015-2020
  • Table 25 NBO Company Shares of Digestive Remedies: % Value 2016-2020
  • Table 26 LBN Brand Shares of Digestive Remedies: % Value 2017-2020
  • Table 27 Forecast Sales of Digestive Remedies by Category: Value 2020-2025
  • Table 28 Forecast Sales of Digestive Remedies by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Degree of stockpiling in nappy (diaper) rash treatments
  • Competitive product area with little between top three players
  • High birth rate continues to support strong growth in nappy (diaper) rash treatments
RECOVERY AND OPPORTUNITIES
  • Dermatologicals largely unaffected by COVID-19 and growth continues as normal
  • Unit price stability returns to the category, supporting higher demand
  • Prevalence of dermatological conditions remains high due to low hygiene standards
CATEGORY DATA
  • Table 29 Sales of Dermatologicals by Category: Value 2015-2020
  • Table 30 Sales of Dermatologicals by Category: % Value Growth 2015-2020
  • Table 31 NBO Company Shares of Dermatologicals: % Value 2016-2020
  • Table 32 LBN Brand Shares of Dermatologicals: % Value 2017-2020
  • Table 33 LBN Brand Shares of Hair Loss Treatments: % Value 2017-2020
  • Table 34 Forecast Sales of Dermatologicals by Category: Value 2020-2025
  • Table 35 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025
2020 IMPACT
  • NRT smoking cessation aids remains a marginal category with no growth prospects
KEY DATA FINDINGS

2020 IMPACT
  • Increased demand for sleep aids during early phase of pandemic
  • Medizen and Sigma Pharmaceutical Industries remain in the leading positions
  • Complex and highly regulated registration process discourages new launches
RECOVERY AND OPPORTUNITIES
  • Dampened growth in 2021 due to stockpiling
  • Growth hampered by belief that sleep aids are psychotropic
  • Sales of sleep aids likely to remain low due to limited consumer awareness
CATEGORY DATA
  • Table 36 Sales of Sleep Aids: Value 2015-2020
  • Table 37 Sales of Sleep Aids: % Value Growth 2015-2020
  • Table 38 NBO Company Shares of Sleep Aids: % Value 2016-2020
  • Table 39 LBN Brand Shares of Sleep Aids: % Value 2017-2020
  • Table 40 Forecast Sales of Sleep Aids: Value 2020-2025
  • Table 41 Forecast Sales of Sleep Aids: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Eye car largely unaffected by COVID-19 though increased screen time leads to demand for eye strain products
  • Kahira is the leading name in eye care as its brands continue to attract consumers
  • Low average unit price supports overall sales of eye care
RECOVERY AND OPPORTUNITIES
  • Pollution and increasing use of digital devices expected to maintain growth
  • Severe air pollution continues to support demand for eye care products
  • Drops remains the dominant format in eye care
CATEGORY DATA
  • Table 42 Sales of Eye Care by Category: Value 2015-2020
  • Table 43 Sales of Eye Care by Category: % Value Growth 2015-2020
  • Table 44 NBO Company Shares of Eye Care: % Value 2016-2020
  • Table 45 LBN Brand Shares of Eye Care: % Value 2017-2020
  • Table 46 Forecast Sales of Eye Care by Category: Value 2020-2025
  • Table 47 Forecast Sales of Eye Care by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Less injuries as people stay at home
  • Pharmaplast dominates sales in a highly consolidated product area
  • Low levels of brand loyalty define the competitive environment in wound care
RECOVERY AND OPPORTUNITIES
  • Once people start going out again, wound care will return to pre-COVID-19 value growth
  • Wound care continues to underperform
  • The preference for traditional home-made alternatives to remain a drag on growth
CATEGORY DATA
  • Table 48 Sales of Wound Care by Category: Value 2015-2020
  • Table 49 Sales of Wound Care by Category: % Value Growth 2015-2020
  • Table 50 NBO Company Shares of Wound Care: % Value 2016-2020
  • Table 51 LBN Brand Shares of Wound Care: % Value 2017-2020
  • Table 52 Forecast Sales of Wound Care by Category: Value 2020-2025
  • Table 53 Forecast Sales of Wound Care by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Huge boost to vitamins due to COVID-19, as consumers look to boost their immune health
  • Local companies remain the major players in vitamins
  • Paediatric vitamins remains niche with considerable room for growth
RECOVERY AND OPPORTUNITIES
  • Change in consumer behaviour, once threat of COVID-19 subsides
  • Multivitamins remains dominant due to the value it represents
  • Doctors are not normally consulted before Egyptians purchase vitamins
CATEGORY DATA
  • Table 54 Sales of Vitamins by Category: Value 2015-2020
  • Table 55 Sales of Vitamins by Category: % Value Growth 2015-2020
  • Table 56 Sales of Multivitamins by Positioning: % Value 2015-2020
  • Table 57 NBO Company Shares of Vitamins: % Value 2016-2020
  • Table 58 LBN Brand Shares of Vitamins: % Value 2017-2020
  • Table 59 Forecast Sales of Vitamins by Category: Value 2020-2025
  • Table 60 Forecast Sales of Vitamins by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Consumers choose vitamin over dietary supplements to boost immune system
  • Local player Eva Pharma leads a highly fragmented category, ahead of GSK
  • Dietary deficiencies underpin strong demand for minerals
RECOVERY AND OPPORTUNITIES
  • Post 2020, value sales will return to normal growth levels
  • Wide variety of affordable products supports sales growth
  • High levels of fragmentation likely to remain a feature of dietary supplements
CATEGORY DATA
  • Table 61 Sales of Dietary Supplements by Category: Value 2015-2020
  • Table 62 Sales of Dietary Supplements by Category: % Value Growth 2015-2020
  • Table 63 Sales of Dietary Supplements by Positioning: % Value 2015-2020
  • Table 64 NBO Company Shares of Dietary Supplements: % Value 2016-2020
  • Table 65 LBN Brand Shares of Dietary Supplements: % Value 2017-2020
  • Table 66 Forecast Sales of Dietary Supplements by Category: Value 2020-2025
  • Table 67 Forecast Sales of Dietary Supplements by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • COVID-19 dampens current value growth as product area considered non-essential
  • Eva Pharma remains the strong leader in weight management and wellbeing
  • The preference for traditional and natural weight loss remedies continues to suppress demand
RECOVERY AND OPPORTUNITIES
  • Consumers look to shed weight, post COVID-19
  • Unhealthy lifestyles and high-fat diets remain common among the population
  • The ban on marketing and advertising results in lack of dynamism
CATEGORY DATA
  • Table 68 Sales of Weight Management and Wellbeing by Category: Value 2015-2020
  • Table 69 Sales of Weight Management and Wellbeing by Category: % Value Growth 2015-2020
  • Table 70 NBO Company Shares of Weight Management and Wellbeing: % Value 2016-2020
  • Table 71 LBN Brand Shares of Weight Management and Wellbeing: % Value 2017-2020
  • Table 72 Forecast Sales of Weight Management and Wellbeing by Category: Value 2020-2025
  • Table 73 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Value growth falls as gyms are closed due to COVID-19
  • Optimum Nutrition continues to lead and gains value share in 2020
  • Regulatory uncertainty affects value sales
RECOVERY AND OPPORTUNITIES
  • Post 2021, value growth should return to pre COVID-19 levels
  • Younger consumers drive value sales
  • Local bands have opportunity to gain ground as importers face issues
CATEGORY DATA
  • Table 74 Sales of Sports Nutrition by Category: Value 2015-2020
  • Table 75 Sales of Sports Nutrition by Category: % Value Growth 2015-2020
  • Table 76 NBO Company Shares of Sports Nutrition: % Value 2016-2020
  • Table 77 LBN Brand Shares of Sports Nutrition: % Value 2017-2020
  • Table 78 Forecast Sales of Sports Nutrition by Category: Value 2020-2025
  • Table 79 Forecast Sales of Sports Nutrition by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Healthy value growth, though a degree of stockpiling drives sales
  • Most fragmented consumer health product area
  • Strict regulation and price controls continue to stifle innovation and new product development
RECOVERY AND OPPORTUNITIES
  • Degree of stockpiling in 2020 hampers growth at start of the forecast period
  • Widespread consumer acceptance of herbal remedies continues to support sales
  • Herbal/traditional products faces strong competition from unpackaged alternatives
CATEGORY DATA
  • Table 80 Sales of Herbal/Traditional Products by Category: Value 2015-2020
  • Table 81 Sales of Herbal/Traditional Products by Category: % Value Growth 2015-2020
  • Table 82 NBO Company Shares of Herbal/Traditional Products: % Value 2016-2020
  • Table 83 LBN Brand Shares of Herbal/Traditional Products: % Value 2017-2020
  • Table 84 Forecast Sales of Herbal/Traditional Products by Category: Value 2020-2025
  • Table 85 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Stockpiling lead to high current value growth of nappy (diaper) rash treatments
  • Local players account for significant value share in paediatric consumer health
  • Lack of paediatric consumer health products continues to limit development
RECOVERY AND OPPORTUNITIES
  • Stockpiling leads to lower value sales in some product areas in 2021
  • Paediatric analgesics and paediatric digestive remedies dominant
  • The development of paediatric consumer health held back by strict regulation
CATEGORY DATA
  • Table 86 Sales of Paediatric Consumer Health by Category: Value 2015-2020
  • Table 87 Sales of Paediatric Consumer Health by Category: % Value Growth 2015-2020
  • Table 88 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2020
  • Table 89 NBO Company Shares of Paediatric Consumer Health: % Value 2016-2020
  • Table 90 LBN Brand Shares of Paediatric Consumer Health: % Value 2017-2020
  • Table 91 Forecast Sales of Paediatric Consumer Health by Category: Value 2020-2025
  • Table 92 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025
Note: Product cover images may vary from those shown
Adroll
adroll